Ocugen Says FDA Declines To Issue EUA For Pediatric Use Of COVAXIN

Drug maker, Ocugen, Inc. (OCGN), said on Friday that the U.S. Food and Drug Administration or FDA, has declined to issue an Emergency Use Authorization or EUA, for the pediatric use of COVAXIN to prevent Covid-19.

However, the company said it "intends to continue working with FDA to evaluate the regulatory pathway for the pediatric use of COVAXIN."

Earlier, Ocugen had intended to get EUA for the vaccine to prevent Covid-19 caused by SARS-CoV-2 in the children of the age group of 2 to 18 years.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Nestle Purina PetCare Co. has recalled a limited amount of certain prescription wet dog food citing labeling error, the U.S. Food and Drug Administration said. The recall involves Purina Pro Plan Veterinary Diets EN Gastroenteric Low Fat or PPVD EN Low Fat wet dog food that comes in 13.4 oz cans. Exportadora Copramar is recalling 1260 cases of James Farm frozen raspberries citing potential to be contaminated with Hepatitis A, the U.S. Food and Drug Administration said. The recall involves James Farm branded frozen raspberries identified by UPC Code: 76069501010 and Lot Code - 22-165. American Honda Motor Co, Inc. has recalled about 2,900 units of 2022 model year Honda TRX90X All-Terrain Vehicles (ATVs) sold in the United States for possible crash and injury hazard, according to a statement issued by the U.S. Consumer Product Safety Commission or CPSC.
Follow RTT